受强制性开放获取政策约束的文章 - Xuemei Xie了解详情
无法在其他位置公开访问的文章：1 篇
Emerging drug targets for triple-negative breast cancer: a guided tour of the preclinical landscape
X Xie, J Lee, T Iwase, M Kai, NT Ueno
Expert Opinion on Therapeutic Targets 26 (5), 405-425, 2022
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：11 篇
c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun
X Xie, TS Kaoud, R Edupuganti, T Zhang, T Kogawa, Y Zhao, ...
Oncogene 36 (18), 2599-2608, 2017
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
MEK inhibitor selumetinib (AZD6244; ARRY-142886) prevents lung metastasis in a triple-negative breast cancer xenograft model
C Bartholomeusz, X Xie, MK Pitner, K Kondo, A Dadbin, J Lee, H Saso, ...
Molecular cancer therapeutics 14 (12), 2773-2781, 2015
强制性开放获取政策： US National Institutes of Health
JNK signaling in stem cell self-renewal and differentiation
T Semba, R Sammons, X Wang, X Xie, KN Dalby, NT Ueno
International journal of molecular sciences 21 (7), 2613, 2020
强制性开放获取政策： US National Institutes of Health, Cancer Prevention Research Institute of …
Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer
M Gagliardi, MK Pitner, J Park, X Xie, H Saso, RA Larson, RM Sammons, ...
Scientific reports 10 (1), 8537, 2020
强制性开放获取政策： US National Institutes of Health, Cancer Prevention Research Institute of …
Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP
X Xie, C Bartholomeusz, AA Ahmed, A Kazansky, L Diao, KA Baggerly, ...
Molecular cancer therapeutics 12 (6), 1099-1111, 2013
强制性开放获取政策： US National Institutes of Health
Serotonin analogues as inhibitors of breast cancer cell growth
J Jose, CDJ Tavares, ND Ebelt, A Lodi, R Edupuganti, X Xie, AK Devkota, ...
ACS Medicinal Chemistry Letters 8 (10), 1072-1076, 2017
强制性开放获取政策： US National Institutes of Health
Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway–Dependent Apoptosis
X Xie, J Lee, H Liu, T Pearson, AY Lu, D Tripathy, GR Devi, ...
Molecular cancer therapeutics 20 (2), 296-306, 2021
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Antitumor activity of KW-2450 against triple-negative breast cancer by inhibiting Aurora A and B kinases
K Kai, K Kondo, X Wang, X Xie, MK Pitner, ME Reyes, AM Torres-Adorno, ...
Molecular cancer therapeutics 14 (12), 2687-2699, 2015
强制性开放获取政策： US National Institutes of Health
Identification of the JNK-active triple-negative breast cancer cluster associated with an immunosuppressive tumor microenvironment
T Semba, X Wang, X Xie, EN Cohen, JM Reuben, KN Dalby, JP Long, ...
JNCI: Journal of the National Cancer Institute 114 (1), 97-108, 2022
强制性开放获取政策： US National Institutes of Health, Cancer Prevention Research Institute of …
Maternal embryonic leucine zipper kinase is associated with metastasis in triple-negative breast cancer
X Xie, GB Chauhan, R Edupuganti, T Kogawa, J Park, M Tacam, AW Tan, ...
Cancer research communications 3 (6), 1078-1092, 2023
强制性开放获取政策： US National Institutes of Health, Cancer Prevention Research Institute of …
Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
X Xie, J Lee, JA Fuson, H Liu, T Iwase, K Yun, C Margain, D Tripathy, ...
Biomedicines 11 (3), 735, 2023
强制性开放获取政策： US National Institutes of Health, Cancer Prevention Research Institute of …
出版信息和资助信息由计算机程序自动确定